GSK
805 hedge funds and large institutions have $9.66B invested in GSK in 2023 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 352 increasing their positions, 218 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
805
Holders Change
-5
Holders Change %
-0.62%
% of All Funds
12.88%
Holding in Top 10
13
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-18.75%
% of All Funds
0.21%
New
82
Increased
352
Reduced
218
Closed
69
Calls
$269M
Puts
$167M
Net Calls
+$101M
Net Calls Change
-$162M
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
+$217M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$170M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$56M |
| 4 |
Holocene Advisors
New York
|
+$42.1M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$30.2M |
